2023
DOI: 10.1016/j.ceca.2023.102757
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Ca2+ signaling and Alzheimer's disease: Too much or too little?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 143 publications
0
0
0
Order By: Relevance
“…Theme 3, finally, provides an update about the involvement and role of Ca 2+ signals in pathogenesis and pathology. A wide spectrum of diseases is discussed, including breast cancer [25], neurological disorders, such as Alzheimer's disease [26] and Parkinson's disease [27], chemotherapy-induced neuropathy [28], hepatic diseases [29], cardiac diseases [30], polycystic kidney disease [31], pancreatic diseases [32] and auditory diseases [33].…”
mentioning
confidence: 99%
“…Theme 3, finally, provides an update about the involvement and role of Ca 2+ signals in pathogenesis and pathology. A wide spectrum of diseases is discussed, including breast cancer [25], neurological disorders, such as Alzheimer's disease [26] and Parkinson's disease [27], chemotherapy-induced neuropathy [28], hepatic diseases [29], cardiac diseases [30], polycystic kidney disease [31], pancreatic diseases [32] and auditory diseases [33].…”
mentioning
confidence: 99%